Incannex Healthcare Inc
IXHL0.152USD
-0.458-75.10%
收盘 04/29, 16:00（美东）报价延迟15分钟
2.70M总市值
亏损市盈率 TTM
关于 Incannex Healthcare Inc 公司
Incannex Healthcare Inc. 是一家临床阶段的药物开发公司。该公司正在开发医用大麻素药物产品和迷幻药疗法，用于治疗阻塞性睡眠呼吸暂停 (OSA)、创伤性脑损伤 (TBI) 和脑震荡、肺部炎症（ARDS、COPD、哮喘、支气管炎）、类风湿性关节炎、炎症性肠病、焦虑症、成瘾症和疼痛等。该公司的多元化产品组合包括 28 个不同的研发 (R&D) 项目和 6 个正在进行的临床试验。其临床项目包括IHL-42X阻塞性睡眠呼吸暂停、IHL-675A炎症性肺病、IHL-675A类风湿性关节炎、IHL-675A炎症性肠病、IHL-216A脑震荡和TBI、用于治疗焦虑的PSI-GAD裸盖菇素、MedChew GB带状疱疹后神经痛和MedChew-1401多发性硬化症中的疼痛和痉挛。
公司简介
公司代码IXHL
公司名称Incannex Healthcare Inc
上市日期Mar 18, 2022
成立日期2023
CEOMr. Joel Latham
员工数量9
证券类型Ordinary Share
年结日Mar 18
公司地址18 East 50th Street
城市NEW YORK
上市交易所NASDAQ Global Market Consolidated
国家United States of America
邮编10022
电话
网址
公司代码IXHL
上市日期Mar 18, 2022
成立日期2023
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Joel Latham
Mr. Joel Latham
President, Chief Executive Officer, Executive Director
President, Chief Executive Officer, Executive Director
1.58M
--
Dr. George Anastassov
Dr. George Anastassov
Non-Executive Independent Director
Non-Executive Independent Director
769.72K
--
Mr. Peter Widdows
Mr. Peter Widdows
Non-Executive Independent Director
Non-Executive Independent Director
270.85K
--
Mr. Joseph Swan
Mr. Joseph Swan
Chief Financial Officer, Controller, Treasurer, Company Secretary
Chief Financial Officer, Controller, Treasurer, Company Secretary
169.20K
+146.20%
Mr. Troy Valentine
Mr. Troy Valentine
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
--
--
Mr. Lekhram Changoer
Mr. Lekhram Changoer
Chief Technology Officer
Chief Technology Officer
--
--
Dr. Luigi M. (Lou) Barbato, M.D.
Dr. Luigi M. (Lou) Barbato, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Robert B. Clark
Mr. Robert B. Clark
Non-Executive Independent Director
Non-Executive Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Joel Latham
Mr. Joel Latham
President, Chief Executive Officer, Executive Director
President, Chief Executive Officer, Executive Director
1.58M
--
Dr. George Anastassov
Dr. George Anastassov
Non-Executive Independent Director
Non-Executive Independent Director
769.72K
--
Mr. Peter Widdows
Mr. Peter Widdows
Non-Executive Independent Director
Non-Executive Independent Director
270.85K
--
Mr. Joseph Swan
Mr. Joseph Swan
Chief Financial Officer, Controller, Treasurer, Company Secretary
Chief Financial Officer, Controller, Treasurer, Company Secretary
169.20K
+146.20%
Mr. Troy Valentine
Mr. Troy Valentine
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
--
--
Mr. Lekhram Changoer
Mr. Lekhram Changoer
Chief Technology Officer
Chief Technology Officer
--
--
收入明细
FY2025Q1
FY2024
FY2024Q4
FY2022
暂无数据
地区USD
名称
营收
占比
Australia
74.00K
0.00%
业务
地区
暂无数据
股东统计
更新时间: 4月8日 周二
更新时间: 4月8日 周二
持股股东
股东类型
持股股东
股东统计
占比
L1 Capital Global Opportunities Master Fund Ltd.
7.00%
S.H.N. Financial Investments Ltd
7.00%
Latham (Joel)
5.73%
Valentine (Troy Robert)
3.76%
Anastassov (George)
2.79%
Other
73.71%
持股股东
股东统计
占比
L1 Capital Global Opportunities Master Fund Ltd.
7.00%
S.H.N. Financial Investments Ltd
7.00%
Latham (Joel)
5.73%
Valentine (Troy Robert)
3.76%
Anastassov (George)
2.79%
Other
73.71%
股东类型
股东统计
占比
Individual Investor
16.57%
Corporation
14.01%
Investment Advisor
0.82%
Research Firm
0.37%
Investment Advisor/Hedge Fund
0.07%
Other
68.18%
机构持股
更新时间: 3月4日 周二
更新时间: 3月4日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q1
36
9.08M
33.58%
+3.85M
2024Q4
34
5.22M
29.25%
-10.87K
2024Q3
35
5.23M
32.43%
+928.92K
2024Q2
32
5.32M
33.29%
+935.04K
2024Q1
33
4.38M
27.39%
+2.50M
2023Q4
26
4.32M
27.01%
+2.81M
2023Q3
13
32.37K
0.05%
-34.33K
2023Q2
11
12.21K
0.02%
-63.09K
2023Q1
10
20.53K
0.03%
-60.83K
2022Q4
10
50.18K
0.08%
-3.79K
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
L1 Capital Global Opportunities Master Fund Ltd.
1.93M
7%
+1.93M
--
Mar 10, 2025
S.H.N. Financial Investments Ltd
1.93M
7%
+1.93M
--
Mar 10, 2025
Latham (Joel)
1.58M
5.73%
--
--
Oct 21, 2024
Valentine (Troy Robert)
1.04M
3.76%
--
--
Oct 21, 2024
Anastassov (George)
769.72K
2.79%
--
--
Oct 21, 2024
Changoer Lekhram
639.55K
2.32%
--
--
Oct 21, 2024
Widdows (Peter)
270.85K
0.98%
--
--
Oct 21, 2024
Swan (Joseph)
169.20K
0.61%
+100.48K
+146.20%
Oct 23, 2024
AdvisorShares Investments, LLC
165.50K
0.6%
+38.51K
+30.32%
Dec 31, 2024
Clark (Robert)
100.00K
0.36%
--
--
Oct 21, 2024
查看更多
持股ETF
更新时间: 4月6日 周日
更新时间: 4月6日 周日
机构名称
占比
AdvisorShares Psychedelics ETF
4.37%
Amplify Alternative Harvest ETF
0%
AdvisorShares Psychedelics ETF
占比4.37%
Amplify Alternative Harvest ETF
占比0%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据